Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant

Signal Transduct Target Ther. 2022 Jul 19;7(1):243. doi: 10.1038/s41392-022-01062-3.

Gen Li^#¹, Zhongcheng Zhou^#¹, Peng Du^#¹, Meixiao Zhan^#², Ning Li¹, Xinxin Xiong¹, Shengjun Tang¹, Miao Man^{2

3

4}, Daniel T Baptista-Hon^{5

6

7}, Ligong Lu⁸

¹ Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
² Zhuhai Precision Medicine Center, Zhuhai People's Hospital, The First Affiliated Hospital of Faculty of Medicine, Macau University of Technology, Zhuhai, Guangdong, China.
³ Department of Bioinformatics and AI, Guangzhou Laboratory, Guangzhou, China.
⁴ University Hospital and Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Taipa, 999078, Macau, China.
⁵ Zhuhai Precision Medicine Center, Zhuhai People's Hospital, The First Affiliated Hospital of Faculty of Medicine, Macau University of Technology, Zhuhai, Guangdong, China. dbaptistahon@must.edu.mo.
⁶ Department of Bioinformatics and AI, Guangzhou Laboratory, Guangzhou, China. dbaptistahon@must.edu.mo.
⁷ University Hospital and Center for Biomedicine and Innovations, Faculty of Medicine, Macau University of Science and Technology, Taipa, 999078, Macau, China. dbaptistahon@must.edu.mo.
⁸ Zhuhai Precision Medicine Center, Zhuhai People's Hospital, The First Affiliated Hospital of Faculty of Medicine, Macau University of Technology, Zhuhai, Guangdong, China. lu_ligong@163.com.

^# Contributed equally.

No abstract available

Publication types